Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2026)

Viemed Healthcare's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $197.4 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 10.83% year-over-year to $197.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $783.5 million (up 13.77% YoY) and the FY2025 annual result came in at $199.2 million, up 12.47% from the prior year.
• Liabilities and Shareholders Equity was $197.4 million for Q1 2026 at Viemed Healthcare, down from $199.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $202.4 million in Q3 2025 and bottomed at $115.9 million in Q2 2022.
• A 5-year average of $157.4 million and a median of $154.9 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 0.78% — and 2023, when it jumped 32.34%.
• Viemed Healthcare's Liabilities and Shareholders Equity stood at $117.0 million in 2022, then jumped by 32.34% to $154.9 million in 2023, then advanced by 14.32% to $177.1 million in 2024, then grew by 12.47% to $199.2 million in 2025, then decreased by 0.9% to $197.4 million in 2026.
• Business Quant data shows VMD's Liabilities and Shareholders Equity at $197.4 million in Q1 2026, $199.2 million in Q4 2025, and $202.4 million in Q3 2025.